Lack of recurrence of imatinib-induced interstitial lung disease with nilotinib

MeSH terms

• Aged
• Antineoplastic Agents / adverse effects*
• Benzamides
• Humans
• Imatinib Mesylate
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
• Lung Diseases, Interstitial / chemically induced*
• Lung Diseases, Interstitial / drug therapy
• Lung Diseases, Interstitial / pathology
• Male
• Neoplasm Recurrence, Local / diagnosis
• Neoplasm Recurrence, Local / prevention & control*
• Piperazines / adverse effects*
• Protein-Tyrosine Kinases / antagonists & inhibitors
• Pyrimidines / adverse effects*
• Pyrimidines / therapeutic use*
• Tomography, X-Ray Computed
• Treatment Outcome